We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current IDXG market cap is 5.51M. The company's latest EPS is USD 0.1821 and P/E is 6.86.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 24.12M | 32.89M | 41.65M | 32.06M | 40.21M |
| Operating Income | -26.42M | -26.07M | -14M | -3.62M | 2.8M |
| Net Income | -27.16M | -29.48M | -14.94M | -21.96M | 802k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 69.05M | 45.68M | 38.43M | 15.98M | 13.02M |
| Total Liabilities | 29.85M | 28.23M | 34.31M | 32.52M | 28.16M |
| Total Equity | 13.03M | -29.08M | -42.42M | -63.07M | -61.67M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -18.96M | -13.98M | -8.72M | -7.69M | 3.79M |
| Investing | -13.95M | -1.58M | -315k | 6.21M | -87k |
| Financing | 29.16M | 16.61M | 8.98M | 3M | -5.03M |
| Market Cap | 5.51M |
| Price to Earnings Ratio | 6.86 |
| Price to Sales Ratio | 0.14 |
| Price to Cash Ratio | 1.57 |
| Price to Book Ratio | -0.36 |
| Dividend Yield | - |
| Shares Outstanding | 4.4M |
| Average Volume (1 week) | 2.14k |
| Average Volume (1 Month) | 7.14k |
| 52 Week Change | 31.58% |
| 52 Week High | 3.54 |
| 52 Week Low | 0.5195 |
| Spread (Intraday) | 0.18 (13.53%) |
| Company Name | Interpace Biosciences Inc (QX) |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.interpace.com |
| Industry | business services, nec (7389) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
